Ro

Introducing Ro’s GLP-1 Supply Tracker – a free, open access tool to help patients and providers find out which medications are available (and where) and which aren’t. https://lnkd.in/en5qTGAa We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1️⃣ Clearly showing which GLP-1s are currently in shortage by drug and dose 2️⃣ Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3️⃣ Letting anyone join our “Supply List” that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4️⃣ Sending automated notifications to patients and providers who sign-up letting them know when a drug’s status changes on the FDA’s list. Our hope is that this tracker will help ease the burden that drug shortages have placed on patients and providers, and increase access to these life-changing treatments.

Today, we’re sharing research highlighting the many ways accessing obesity care through Ro can change lives. Patients come to Ro to live happier, more fulfilled lives: 🌟 80% of patients report increased confidence 🏃♀️ 66% are back to enjoying physical activities they love 👖 94% fit into their old clothes after a year with Ro Check more ways that we’re helping our patients achieve their goals: https://lnkd.in/eXPjmw_2

#OW2024 is underway in San Antonio, TX, and we’re excited to share our latest research. The research sheds light on key issues in obesity medicine today, including: 💡How telehealth can bridge access to weight management care for patients living in rural areas or care deserts. 💡Patients' diverse motivations for weight loss and their relationship to quality of life. 💡The role technology plays in monitoring and managing side effects among patients treated with GLP-1s. Follow the link below to learn more about what we're presenting at ObesityWeek: https://lnkd.in/eJnAFMbV #obesitycare #research #insights

Ro turns seven today! Cheers to an incredible seven years of making healthcare easier and more effective for patients, while empowering them to achieve their health goals. 🎉 In celebration, we invited a few Ro Body members to share their stories with Ro'ers. Hearing their experiences reminded us of our purpose: helping patients live happier, more fulfilling lives. Swipe through to see just a glimpse of the powerful stories our patients shared with us!

"It's a win for us when [patients] get access to their medication at an affordable price...We hope that competition leads to the prices coming down." Ro CEO Zachariah Reitano joined Yahoo Finance’s Market Domination with Anjalee Khemlani to discuss the importance of accessible obesity treatments and the rapidly evolving GLP-1 landscape. Watch the full interview here: https://lnkd.in/enygVmWb

"Cost, quality, and convenience – and not having to trade off on any of those is why patients come to us." Ro CEO Zachariah Reitano joined Dan Primack at #AxiosBFD this week to talk about the incredible potential of GLP-1s in healthcare and share more about Ro's journey to helping millions of patients achieve their goals. You can watch their talk here: https://lnkd.in/dSe_sVGD 

We’re excited to see our patient, Danielle, featured in Verywell Mind, where she shares her experience with food noise. https://lnkd.in/ekFRsrxd Since beginning GLP-1 treatment with Ro, Danielle has found relief from food noise, allowing her to focus on what matters most: quality time with her family. Now, she’s enjoying moments like coaching her son’s basketball team and fun date nights with her husband. 

"At Ro, we believe in a strong attract, strong repel culture. It’s a self-selecting group that deeply believes in a shared set of principles." Congratulations to Ro CEO Zachariah Reitano for being named one of Reuters' Future Leaders in Healthcare. You can download the full report here: https://lnkd.in/eGdjzgCU

What are the best ways to maintain muscle while on GLP-1s? In part 2 of our series, Ro advisors, David Allison and Beverly Tchang, along with Ro’ers, Raoul Manalac and Lauren Broffman, PhD, discuss the relationship between weight loss and muscle mass and strength. Read their insights on maintaining both with lifestyle interventions alongside treatment with GLP-1 medications here: https://lnkd.in/dZ_Tdyz2

Curious about how anti-Müllerian hormone (AMH) levels impact fertility? Our latest research, published in the Journal of Fertility and Sterility, offers the largest cohort study to date on how AMH levels impact natural conception. These findings can provide valuable insights for patients and healthcare providers when making informed decisions about family planning. Want to know more? Read the full blog for a closer look at the study and what the findings mean: https://lnkd.in/dC5GA9VY #Fertility #ReproductiveHealth #HealthcareResearch #FamilyPlanning #AMH